companydata.dkGemCap Biotech ApS: Financial statements 2020
CVR: 38189174
GemCap Biotech ApS (CVR 38189174) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK 6,750. The solvency ratio was 100%.
- Profit/Loss
- 0 kr.
- Equity
- 6,750 kr.
- Total Assets
- 6,750 kr.
How creditworthy is GemCap Biotech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
GemCap Biotech ApS has published its annual report for 2019. The net result was DKK 0.
As of May 28, 2020, Werner Schmidt has left the board of directors of GemCap Biotech ApS.
As of January 27, 2020, Werner Schmidt has joined the board of directors of GemCap Biotech ApS.
As of January 27, 2020, Werner Ernst Spiegler has left the board of directors of GemCap Biotech ApS.
About GemCap Biotech ApS
GemCap Biotech ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2016 and dissolved in 2024. The company was registered under the industry Anden finansiel formidling undtagen forsikring og pensionsforsikring, i.a.n.. In 2023, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK 27,000.